Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 35

    Syringes and needles being sold at 214 to 1251 percent margin: NPPA

    Syringes and needles being sold at 214 to 1251 percent margin: NPPA

    Ruby Khatun Khatun7 March 2018 4:13 PM IST
    New Delhi: NPPA seems to be shifting its focus on syringes and needles, as these medical equipment are being sold at very high margins.The National...
    NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

    NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details

    Ruby Khatun Khatun6 March 2018 3:41 PM IST
    New Delhi: National drug pricing regulator NPPA said it has fixed the retail/ceiling prices of 12 formulations including those used for the treatment...
    Refix ceiling price of Sun Pharma

    Refix ceiling price of Sun Pharma's ciprofloxacin 250mg, 500mg tablets: DoP tells NPPA

    Ruby Khatun Khatun5 March 2018 5:48 PM IST
    The Department of Pharmaceuticals (DoP) has given its decision in favour of Sun Pharma against the price fixing of ciprofloxacin 250mg and...
    Last chance for medical devices firms to submit price data: NPPA

    Last chance for medical devices firms to submit price data: NPPA

    Ruby Khatun Khatun5 March 2018 11:00 AM IST
    New Delhi: National drug pricing regulator NPPA has said medical devices makers and importers are being given the last opportunity to submit data...
    Tata Trusts partners with Telangana to upgrade cancer care

    Tata Trusts partners with Telangana to upgrade cancer care

    Ruby Khatun Khatun3 March 2018 10:30 AM IST
    Hyderabad: The Telangana government and Tata Trusts signed an MoU to deliver high-quality affordable cancer care through a three-tier model and...
    Ultrasound, CT scanners, MRI, X-Ray to fall under Drugs Act: Drug Technical Advisory Board

    Ultrasound, CT scanners, MRI, X-Ray to fall under Drugs Act: Drug Technical Advisory Board

    Ruby Khatun Khatun2 March 2018 12:36 PM IST
    New Delhi: To control the import, manufacturing, and sale of the Imaging and endoscopic equipment like ultrasound machines, CT scanners, magnetic...
    Big Boost to Medical Equipment Sector: AP signs MOUs worth Rs 8000 crore

    Big Boost to Medical Equipment Sector: AP signs MOUs worth Rs 8000 crore

    Ruby Khatun Khatun26 Feb 2018 5:17 PM IST
    Visakhapatnam: Andhra Pradesh will soon get a big push in the medical equipment and devices sector as the state government has signed 25 MoUs with...
    NPPA allows companies to withdraw stent from market

    NPPA allows companies to withdraw stent from market

    Ruby Khatun Khatun22 Feb 2018 3:34 PM IST
    New Delhi: Drug price regulator NPPA said it has decided not to stop any coronary stent manufacturer from withdrawing products from the Indian...
    344 Fixed-Dose Combinations: DCGI constitutes a sub-committee to relook the matter

    344 Fixed-Dose Combinations: DCGI constitutes a sub-committee to relook the matter

    Ruby Khatun Khatun21 Feb 2018 10:58 AM IST
    New Delhi: Through a recent notification, Directorate General of Health Services has constituted a subcommittee for having a relook in the case of...
    Oxytocin misuse: CDSCO calls manufacturers for discussion

    Oxytocin misuse: CDSCO calls manufacturers for discussion

    Ruby Khatun Khatun20 Feb 2018 3:15 PM IST
    New Delhi: Through a notification dated 16th Feb 2018, Central Drugs Standard Control Organization (CDSCO) has called all the Manufacturers of...
    Stern action to be taken against erring drug manufacturers: HP Health Minister

    Stern action to be taken against erring drug manufacturers: HP Health Minister

    Ruby Khatun Khatun18 Feb 2018 11:51 AM IST
    Shimla: Himachal Pradesh Government is committed to providing better health facilities to people in the state and no compromise will be made in the...
    Govt to come out with new pharma policy: Ananth Kumar

    Govt to come out with new pharma policy: Ananth Kumar

    Medical Dialogues Bureau17 Feb 2018 10:19 AM IST
    Bengaluru: The government is looking to bring in a new pharma policy for implementing the proposed health care plan across the country in the next...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19

    CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok